Nin Darren Z, Chen Ya-Wen, Talmo Carl T, Hollenbeck Brian L, Mattingly David, Zvi Yoav, Niu Ruijia, Chang David C, Smith Eric L
Department of Orthopedic Surgery, New England Baptist Hospital, Boston, Massachusetts.
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
J Knee Surg. 2025 Mar;38(4):195-200. doi: 10.1055/a-2451-8845. Epub 2024 Oct 24.
Injections are a common preoperative treatment for patients who eventually undergo total knee arthroplasty (TKA). However, recent studies have shown a relationship between preoperative injections and adverse outcomes following surgery. The purpose of this study was to characterize the type of intra-articular procedure patients receive in the acute period prior to surgery and determine their association with postoperative periprosthetic joint infection (PJI).An observational cohort study was conducted using the Merative MarketScan databases. Patients who underwent primary TKA between April 1, 2019, and July 4, 2021, were included in the study. Patients were grouped according to the type of intra-articular procedure they received within the 90-day period prior to TKA: (i) intra-articular hyaluronic acid (IA-HA), (ii) intra-articular corticosteroid (IA-CS), (iii) aspiration, and (iv) no drug injections or aspirations. The primary outcome was the postoperative 180-day PJI rate.A total of 43,219 patients were included in the study. About 11.8% of patients were found to have received at least one injection or aspiration in the 90 days prior to their TKA. The most common injection performed was IA-CS (78.3%), followed by aspiration (13.0%) and IA-HA (8.7%). No image guidance was performed for 92.3% of injections, with most being administered between 61 and 90 days before surgery (93.6%). Rates of PJI at 180 days were similar between patients with and without injections (OR = 1.11, = 0.569). Neither drug type nor image guidance had an effect on the overall postoperative PJI rate.Injections performed prior to TKA do not increase the risk of developing postoperative PJI.
注射是最终接受全膝关节置换术(TKA)患者常见的术前治疗方法。然而,最近的研究表明术前注射与术后不良结局之间存在关联。本研究的目的是描述患者在手术急性期接受的关节内治疗类型,并确定其与术后假体周围关节感染(PJI)的关联。
使用默克多市场扫描数据库进行了一项观察性队列研究。纳入了2019年4月1日至2021年7月4日期间接受初次TKA的患者。根据患者在TKA前90天内接受的关节内治疗类型进行分组:(i)关节内透明质酸(IA-HA),(ii)关节内皮质类固醇(IA-CS),(iii)抽吸,以及(iv)未进行药物注射或抽吸。主要结局是术后180天的PJI发生率。
共有43219名患者纳入研究。约11.8%的患者在TKA前90天内接受了至少一次注射或抽吸。最常见的注射是IA-CS(78.3%),其次是抽吸(13.0%)和IA-HA(8.7%)。92.3%的注射未进行影像引导,大多数注射在手术前61至90天进行(93.6%)。有注射和无注射患者术后180天的PJI发生率相似(OR = 1.11,P = 0.569)。药物类型和影像引导均未对总体术后PJI发生率产生影响。
TKA前进行的注射不会增加术后发生PJI的风险。